Correlation Between Suzhou Novoprotein and Runjian Communication

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Runjian Communication at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Runjian Communication into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Runjian Communication Co, you can compare the effects of market volatilities on Suzhou Novoprotein and Runjian Communication and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Runjian Communication. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Runjian Communication.

Diversification Opportunities for Suzhou Novoprotein and Runjian Communication

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Suzhou and Runjian is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Runjian Communication Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Runjian Communication and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Runjian Communication. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Runjian Communication has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Runjian Communication go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Runjian Communication

Assuming the 90 days trading horizon Suzhou Novoprotein Scientific is expected to under-perform the Runjian Communication. But the stock apears to be less risky and, when comparing its historical volatility, Suzhou Novoprotein Scientific is 1.23 times less risky than Runjian Communication. The stock trades about -0.06 of its potential returns per unit of risk. The Runjian Communication Co is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  4,561  in Runjian Communication Co on November 6, 2024 and sell it today you would lose (1,349) from holding Runjian Communication Co or give up 29.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Suzhou Novoprotein Scientific  vs.  Runjian Communication Co

 Performance 
       Timeline  
Suzhou Novoprotein 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Suzhou Novoprotein Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Runjian Communication 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Runjian Communication Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Runjian Communication may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Suzhou Novoprotein and Runjian Communication Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Suzhou Novoprotein and Runjian Communication

The main advantage of trading using opposite Suzhou Novoprotein and Runjian Communication positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Runjian Communication can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Runjian Communication will offset losses from the drop in Runjian Communication's long position.
The idea behind Suzhou Novoprotein Scientific and Runjian Communication Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume